Knowledge, attitudes, and practices of Croatian pediatricians and pediatrics residents about RSV infection
- PMID: 40328920
- PMCID: PMC12055964
- DOI: 10.1038/s41598-025-01021-2
Knowledge, attitudes, and practices of Croatian pediatricians and pediatrics residents about RSV infection
Abstract
Respiratory syncytial virus (RSV) remains a significant global health challenge, particularly for young children and the elderly. This study examines Croatian pediatricians' and pediatric residents' knowledge, attitudes, and practices regarding RSV infection and its prevention. A cross-sectional survey was conducted among members of the Croatian Pediatric Association from June to August 2023. The survey included demographic data, knowledge about RSV, risk perception across age groups, and attitudes toward RSV vaccines and monoclonal antibodies (mAbs). Logistic regression analyses were conducted to identify factors influencing knowledge, attitudes, and practice outcomes. A total of 196 participants fulfilled the survey. General knowledge scores were comparable between pediatricians and residents. Pediatricians demonstrated higher risk perception for RSV in adults (OR = 4.89, 95% CI 1.91-12.54, p = 0.001). Attitudes toward RSV vaccines and mAbs were largely favorable, with prior experience in mAb use emerging as a key predictor of positive attitudes (OR = 2.10, 95% CI 1.07-4.12, p = 0.032). Regional differences were notable, with participants from Adriatic Croatia exhibiting more favorable attitudes toward mAb use than those in Pannonian Croatia (OR = 3.82, 95% CI 1.66-8.79, p = 0.002). Gender also influenced attitudes, with male physicians more likely to recognize mAb efficacy in preventing RSV infections (OR = 3.07, 95% CI 1.44-6.54, p = 0.004). The findings highlight favorable attitudes toward RSV prevention among Croatian pediatricians and residents, with variations influenced by mAb experience, regional factors, and gender. These insights emphasize the importance of targeted educational efforts to enhance the adoption of RSV preventive strategies.
Keywords: Attitudes; Croatian; Knowledge; Nirsevimab; Palivizumab; Practice; Respiratory syncytial virus; Vaccines.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Ethics approval: The investigation was performed in accordance with relevant guidelines/regulations and approved by the Ethics Committee of the University Hospital of Split (No. 2181 − 147/01/06/LJ.Z.-23-02; Approved on May 23rd, 2023).
Figures



References
-
- Wang, X. et al. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: A systematic review and meta-analysis of aggregated and individual participant data. Lancet14, S0140–673600138 (2024). - PubMed
-
- Simões, E. A. F. Respiratory syncytial virus disease in young children and older adults in Europe: A burden and economic perspective. J. Infect. Dis.226, S1–S9 (2022). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical